Last update 14 Dec 2024
HSK40118
Last update 14 Dec 2024
Overview
Basic Info
Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms HSK 40118, HSK-40118, HSK40118 |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HSK40118A Phase I, Open-label, Dose-escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of HSK40118 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC
评价HSK40118片在EGFR突变的晚期非小细胞肺癌患者中的安全性、耐受性以及药代/药效动力学的I期临床研究
[Translation] A phase I clinical study to evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics of HSK40118 tablets in patients with advanced non-small cell lung cancer with EGFR mutations
100 Clinical Results associated with HSK40118
Login to view more data
100 Translational Medicine associated with HSK40118
Login to view more data
100 Patents (Medical) associated with HSK40118
Login to view more data
100 Deals associated with HSK40118
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| EGFR positive non-small cell lung cancer | Phase 1 | CN | 24 Mar 2023 | |
| EGFR-mutated non-small Cell Lung Cancer | Phase 1 | CN | 24 Mar 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free